18F-LY3950321

N/A

Report date: 2025/11/26 17:57:24

Base Information

Drug Name18F-LY3950321

Drug Alias Name18F-LY395032118F-MNI-125618F-LY3950321-01

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionPositron-emission tomography enhancersGranzyme B binders

TargetsGranzyme B

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAvid Radiopharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvid Radiopharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A